SUSQUEHANNA INTERNATIONAL GROUP, LLP - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 84 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$37,920
-76.9%
12,000
-71.7%
0.00%
Q2 2023$164,262
-68.9%
42,445
-77.8%
0.00%
Q1 2023$528,699
+1133.2%
190,866
+701.4%
0.00%
Q4 2022$42,872
-45.7%
23,818
-35.9%
0.00%
Q3 2022$79,000
-76.3%
37,170
-70.1%
0.00%
Q2 2022$334,000
-63.5%
124,217
-41.1%
0.00%
Q1 2022$914,000
-59.3%
210,895
-51.4%
0.00%
Q4 2021$2,248,000
+50.1%
433,704
+77.8%
0.00%
Q3 2021$1,498,000
+189.7%
243,945
+376.1%
0.00%
Q2 2021$517,00051,2360.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders